Anti-PD-1 Therapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer. (NCT04720131) | Beijing Friendship Hospital | 2021-01-01 |
Track Anti-PD-1 Therapy automatically
Every clearance here is in the API, with alerts when new ones post.